121-135 of 266
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
NeuroFrontiersGene Therapy Safety in DMD: How to Identify Common Immune Reactions
Optimizing DMD Care Through Multidisciplinary Collaboration
NeuroFrontiersOptimizing DMD Care Through Multidisciplinary Collaboration
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
NeuroFrontiersSymptom Control in gMG: Comparing Ravulizumab and Efgartigimod
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
On the Frontlines of CIDPEmpowering Patients with CIDP: Education, Support, and Personalized Care Strategies
New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
On the Frontlines of CIDPNew Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
NeuroFrontiersUpdates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
- advertisement
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
NeuroFrontiersHow Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
NeuroFrontiersAnti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
Evolving Strategies in Limited-Stage Small Cell Lung Cancer Management
Deep Breaths: Updates from CHESTEvolving Strategies in Limited-Stage Small Cell Lung Cancer Management
Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
Deep Breaths: Updates from CHESTUnderstanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
NeuroFrontiersEvaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
NeuroFrontiersQuality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
- advertisement
Debunking gMG Myths: Counseling Strategies That Change the Conversation
NeuroFrontiersDebunking gMG Myths: Counseling Strategies That Change the Conversation
Evaluating High- vs. Low-Dose Corticosteroids in Acute IPF Exacerbations
Clinician's RoundtableEvaluating High- vs. Low-Dose Corticosteroids in Acute IPF Exacerbations
Improving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes
Heart MattersImproving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes
